Join
Live feed
·
INSIDERFilingvia Quantisnow
KALA BIO Inc. logo

Director Blumenkranz Mark S. was granted 1,400 shares, increasing direct ownership by 12% to 13,091 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KALA· KALA BIO Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALA (KALA BIO Inc.) and more on Quantisnow.